EUVIMEDEUVIMED entdecken
Crossref

Genomic and Metabolite Analysis-Driven Revision of Basidiomycete Natural Product Biosynthetic Pathway

Kenji Watanabe

Chemical and Pharmaceutical Bulletin · 2025

DOI: 10.1248/cpb.c25-00594 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Chemical and Pharmaceutical Bulletin, 2025. Verfasst von Kenji Watanabe. Beteiligte Einrichtung: Department of Pharmaceutical Sciences, University of Shizuoka. Hauptthemen laut MEDLINE: Biological Products, Genomics, Basidiomycota. Die Arbeit nennt 21 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The biosynthetic study of secondary metabolites in ectomycorrhizal mushrooms has been hindered by limited mycelial growth and transcriptional silencing of biosynthetic genes under artificial conditions. Ustalic acid, a Na+/K+-ATPase inhibitor and a common cause of mushroom poisoning in Japan, was originally identified in the fruiting body of Tricholoma kakishimeji and was thought to be absent in its mycelium. Here, we demonstrate for the first time the production of ustalic acid in the cultured mycelia of T. stans and T. albobrunneum, two species that were recently segregated from T. ustale by phylogenetic analyses. LC-MS profiling also detected polyporic acid and additional ions consistent with oxidized derivatives of polyporic acid but failed to identify phlebiarubrone, which was previously considered as the biosynthetic precursor of ustalic acid. Genome sequencing and bioinformatic analysis of the sequence information identified a candidate biosynthetic gene cluster for ustalic acid. This cluster was named the uta cluster, and heterologous expression of the uta genes in Aspergillus nidulans afforded polyporic acid, supporting its role in the scaffold assembly. While the downstream biosynthetic steps remain to be investigated, this work establishes the basis for future biochemical and genetic studies of ustalic acid biosynthesis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Biological ProductsGenomicsBasidiomycotaBiosynthetic PathwaysMultigene FamilyPhylogeny

Stichwörter der Autor:innen

biosynthetic gene clusterectomycorrhizal mushroompolyporic acidsecondary metaboliteustalic acid

Substanzen

Biological Products

Autor:innen und Institutionen

  • Department of Pharmaceutical Sciences, University of Shizuoka.

Zitieren

APA

Watanabe, K. (2025). Genomic and Metabolite Analysis-Driven Revision of Basidiomycete Natural Product Biosynthetic Pathway. Chemical and Pharmaceutical Bulletin. https://doi.org/10.1248/cpb.c25-00594

Vancouver

Watanabe K. Genomic and Metabolite Analysis-Driven Revision of Basidiomycete Natural Product Biosynthetic Pathway. Chemical and Pharmaceutical Bulletin. 2025. doi:10.1248/cpb.c25-00594

BibTeX
@article{Watanabe2025,
  author = {Watanabe, Kenji},
  title = {Genomic and Metabolite Analysis-Driven Revision of Basidiomycete Natural Product Biosynthetic Pathway},
  journal = {Chemical and Pharmaceutical Bulletin},
  year = {2025},
  doi = {10.1248/cpb.c25-00594}
}
Kostenlos starten →